Plenary Session 5: Hemoglobin F and Hydroxyurea in Sickle Cell Disease

6 Jun 2025 08:30 10:00
Prof Ambroise Wonkam Co-Chair
Prof Mark Gladwin Co-Chair
Time Session
08:30
10:00
Harnessing African Populations Genomic Variation to Improve Our Understanding of HbF Modifiers in Sickle Cell Disease
Prof Ambroise Wonkam Speaker
Base editing to induce fetal hemoglobin expression.
Dr Gregory Newby Speaker
Improving Access to Hydroxyurea for Sickle Cell Disease in Africa: What Should Be Done?
Prof Leon Tshilolo Speaker